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Aim. Antigenic expression in epithelial cells can be heterogeneous which may pose a problem in immunohistochemical (IHC)
analysis of tumor markers, in particular, predictive markers like HER2. Studies have shown that epithelial cells have distinct apical
and basolateral domains which are separated by tight junctions. The cell membrane in these two domains has a different composition
of macromolecules and hence can have variable antigen expression on immunohistochemistry. In our study, we aimed to investigate
this phenomenon of basolateral versus circumferential IHC staining of HER2 in gastric/GE adenocarcinoma. Methods. We selected
45 cases of gastric/GE adenocarcinoma and evaluated equal number of specimens (15 each) showing well-differentiated, moderately
differentiated, and poorly differentiated morphology. All cases had 3+ HER2 score as per CAP guidelines. HER2-membrane
staining pattern in all specimens was analyzed. Results. Cases with well-differentiated morphology showed only basolateral or
lateral membrane staining in most cases. Poorly differentiated adenocarcinoma samples showed circumferential staining (both
basolateral and luminal) in all cases with highly significant p value. Mixed staining pattern was observed in moderately differentiated
cases. Diffuse expression of E-cadherin in well-differentiated adenocarcinoma and loss in poorly differentiated tumors were also
statistically significant. Conclusion. These findings suggest that HER2 in gastric epithelium has a polarized distribution which is
maintained by the fence function of tight junctions. With progression to high grade cancer, the glandular structural differentiation
in gastric mucosa is lost, along with disruption of tight junctions. This leads to loss of cell polarity and migration of antigens across
the membrane.

1. Introduction
In epithelial tissue, cells characteristically have cell to cell adhesion and an apicobasal membrane polarity; i.e., the apical
and basal membranes have a distinct set of macromolecules.
It has been postulated that tight junctions are important for
maintaining cell polarity [1]. In epithelial tissue, tight junctions are intercellular junctional complexes along the lateral
border of cells forming tight adhesion between cells and
maintaining tissue integrity [2]. Tight junctions perform various functions; two important ones are (i) barrier function,
i.e., allowing selective molecules to diffuse through intercellular space, and (ii) fence function, i.e., dividing the cell
membrane into apical and basolateral surfaces, providing and
maintaining a polarized distribution of certain membrane
components across the cell [3, 4].

Tight junctions can become dysfunctional in cancer and
this plays an important role in tumorigenesis, tumor progression, and metastasis [5]. Loss of tight junctions can result in
disruption of the apicobasal polarity in epithelial cells and
lead to a change in antigen expression by the cell membrane
[6]. In cancer diagnostics, it is common to use immunohistochemical (IHC) techniques to stain various membrane antigens specific to a particular type of tumor. Any changes in the
polarity of cell membrane can cause changes in the staining
pattern.
This study was conducted to study the variable staining
pattern of HER2 (human epidermal growth factor receptor
2) in gastric/gastroesophageal (GE) adenocarcinoma. Level
of E-cadherin expression in tumors of various grades was
also taken into account. HER2 is a plasma membrane bound
receptor and is known to be amplified in certain tumors.
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Breast cancer is most well-known for this, about 15 to 30% are
positive for HER2 overexpression, and this indicates a worse
prognosis when compared to HER2 negative breast cancers
[7, 8]. The prognosis of these patients can be improved by
adding trastuzumab to the treatment regimen. In recent
years, HER2 has also been shown to play an important role in
gastric and gastroesophageal adenocarcinoma and in breast
cancer and some studies have shown that this indicates a
poor prognosis [9, 10] which again can be improved by using
trastuzumab. On an average about 15-18% of gastric and GE
cancer cases are HER2 positive [11]. The ToGA trial in 2010
demonstrated an improved survival rate in patients with
HER2-positive advanced gastric and GE tumors, treated with
trastuzumab, an anti-HER2 monoclonal antibody [12]. Hence,
HER2 testing in such cases is imperative to select patients
for this beneficial targeted therapy. In gastric cancer, the
membranous distribution of the HER2 molecule is mostly
basolateral, in contrast to circumferential membrane staining
HER2 3+ breast cancer [13]. In this study we have used HER2
IHC staining for different histologic grades of gastric adenocarcinoma to investigate differences in patterns of expression
of HER2.

2. Methods
2.1. Tissue Specimens. We selected cases for this study from
the Pathology Department of Aga Khan University Hospital,
Karachi, Pakistan. Surgical resection specimens from patients
diagnosed with intestinal type gastric and GE adenocarcinoma, showing 3 + HER2 IHC staining, were selected. The
IHC semiquantitative scoring on the specimens was done
as per College of American Pathologists (CAP) guidelines
(Rüschoff, Josef et al. 2010). This is universally accepted protocol for scoring of HER2 receptors in gastric and breast biopsies. Strong staining observed at low power in greater than or
equal to 10% of tumor cells was considered to have 3 + HER2
score. The histologic classification of the specimens selected
was based on Lauren’s criteria of gastric adenocarcinoma. The
specimens included in this study were consistent with intestinal type morphology as mentioned in Lauren’s classification
[14]. Only very well-differentiated cases with well-preserved
polarity of neoplastic cells were kept and classified as welldifferentiated cases, while cases with signet ring morphology
were excluded.
2.2. Immunohistochemistry. HER2-protein expression in tumor specimens was analyzed using Hercept test according
to manufacturer’s recommended protocol (DAKO, Carpentaria, CA). These samples were fixed in 10% buffered formalin,
for not more than 72 hours. Sections of resected specimens
were cut with 3-5 um thickness and transferred to antigen
retrieval solution (Tris-EDTA Ph 9). Following this they were
placed in oven at 65 degrees Celsius for 30 minutes and
transferred to P.T Link for 40 minutes, where temperature
was increased from 85 degrees Celsius to 97 degrees Celsius
and then back to 85. Specimens were than washed in buffer
for 5 minutes. Rabbit polyclonal antibody (clone: A0485,
DAKO) was applied at a dilution of 1:1000 for 20 minutes
and then detected by Envision System (DAKO). Positive and
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negative controls provided in the kit were added to each
batch of samples. Ten cases from both well-differentiated
and poorly differentiated adenocarcinomas were also stained
with a monoclonal antibody against anti-human E-cadherin
(clone NCH-38, DAKO) to assess its expression as E-cadherin
is a transmembrane cell adhesion molecule involved in cell
adhesion of epithelial cells and establishment of epithelial
polarization.
The HER2 score was established as per CAP guidelines;
membrane staining (basolateral, lateral, or circumferential)
visible at low magnification (10x) in equal to or greater than
10% of tumor cells in surgical specimens was considered 3+.

3. Results
We observed that well-differentiated gastric and GE adenocarcinoma with prominent glandular differentiation (Figure 1) largely expressed only basolateral HER2 IHC staining
with no luminal staining (Figure 2). Exclusive basolateral and
lateral staining was seen in 10 out of 15 specimens (66.6%),
with no circumferential staining. Meanwhile the remaining
05 cases showed circumferential staining in less than 10%
of tumor cells. In contrast to this, poorly differentiated adenocarcinomas expressed circumferential staining, both basolateral and luminal (Figure 3), consistently in all 15 specimens.
Statistical P value was highly significant (P<0.001) when
staining pattern of well-differentiated group was compared
to poorly differentiated group. Moderately differentiated ones
showed a mixed staining pattern. These showed predominantly basolateral staining; however circumferential staining
was also seen in detached clusters of tumor cells. Figure 4
shows heterogenous pattern of circumferential membrane
staining in poorly differentiated gastric adenocarcinoma
(both 2+ and 3+ HER2 score in cells from the same tumor).
E-cadherin expression was diffuse and strong in all
10/10 cases of well-differentiated adenocarcinoma, while 8/10
poorly differentiated cases showed complete or near complete
loss of E-cadherin. This correlation was also statistically
significant with a p vale of <0.001. Figure 5(a) shows a welldifferentiated adenocarcinoma of stomach stained with Ecadherin showing diffuse strong membrane staining. In
contrast Figure 5(b) shows a poorly differentiated adenocarcinoma of GE junction showing complete loss of E-cadherin
(please note diffuse strong membrane staining of overlying
normal appearing squamous epithelium).

4. Discussion
Tight junctions are a defining characteristic of polarized
epithelial cells (Figure 1), forming functionally distinct apical
and basolateral domains [15–17]. These two domains have
different functions and hence their membrane surfaces differ
in composition [18]. Tight junctions prevent the intermixing
of molecules between the apical and basolateral surfaces of
an epithelial cell. Multiple abnormalities have been elucidated
in junctional complexes of cancerous tissues [19, 20]. Various
scientific studies have shown that loss of tight junction
components can lead to a more homogenous spread of
antigens across the cell membrane [21–23].
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(a)

(b)

Figure 1: (a) Well-differentiated gastric adenocarcinoma on H&E stain. (b) EM showing functional tight junctions in the specimen.

Figure 2: HER2 immunohistochemical staining of well-differentiated adenocarcinoma (note only basolateral staining and no luminal
staining).

(a)

(b)

Figure 3: (a) H&E of poorly differentiated gastric adenocarcinoma. (b) HER2 immunohistochemical staining showing circumferential
staining of tumor cells.

Immunohistochemical techniques are widely used against
epithelial antigens to aid in cancer diagnosis [24]; however,
tumor antigenic heterogeneity can cause uncertainties [25].
Many studies have identified heterogeneous expression of
antigens in normal epithelium and cancer tissues by using
monoclonal antibodies [26–28]. Tumor differentiation and
spatial configuration of cells in a tissue sample can cause

this variable expression of antigens [26, 29]. In gastric adenocarcinoma, HER2 expression can be quite heterogeneous
and mostly there is incomplete membrane staining, which is
the basis for a different criterion for HER2 scoring in gastric
cancer when compared to breast cancer [11]. Similarly, many
studies have shown the variable loss of E-cadherin expression
in gastric adenocarcinomas; as the tumor grade increases and
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Figure 4: HER2 immunohistochemical staining of gastric adenocarcinoma showing antigen heterogeneity (note 2+ and 3+ membrane
staining in the same tumor).

(a)

(b)

Figure 5: (a) Well-differentiated adenocarcinoma of stomach stained with E-cadherin showing diffuse strong membrane staining. (b)
Poorly differentiated adenocarcinoma of GE junction showing complete loss of E-cadherin (please note diffuse strong membrane staining of
overlying normal appearing squamous epithelium).

becomes poorly differentiated, the expression is lost. Most of
the diffuse type (signet ring cell) tumors show the highest
degree of E-cadherin loss [30–32].
In this study, we have identified a variable pattern of
HER2 and E-cadherin expression at various grades of histological differentiation in gastric and GE adenocarcinoma.
Our study shows that HER2 has a polarized distribution in
gastric/GE neoplastic epithelium which becomes disrupted
and more homogenous in poorly differentiated cancer due
to loss of tight junctions. Tight junctions have several membrane and cytoplasmic proteins [33]; some of these such as
occludins, claudins, and zona occludins (ZO proteins) have
been well studied [34–38]. Aberrant expression of claudins
has been noted in epithelial cancer tissues, with both upand downregulation of certain claudins in different types of
cancers [20, 39, 40]. Kimura et al. studied the expression of
occludin and ZO-1 in gastrointestinal tract (GI) epithelium
in both normal and cancer tissue. They identified that these
components are important for the formation and maintenance of well-formed glandular structures that are present in

GI mucosa. Their investigation showed a reduced expression
of occludin and ZO-1 in poorly differentiated gastric and
colorectal adenocarcinoma [41].
Tobioka et al. explored the staining pattern of carcinoembryonic antigen (CEA) in colon cancer and its correlation
with expression of occludin. The study showed an apical distribution of CEA in well-differentiated cancer tissue, which
also had a high expression of occludin. Contrary to this, in the
poorly differentiated counterparts, a circumferential staining
of CEA was observed which correlated with loss of occludin
expression [42]. In a previous study (Pervez et al. 1998) we
observed a similar pattern with epithelial membrane antigen
(EMA) antibody [26]. This antibody showed a homogenous
membrane staining in poorly differentiated adenocarcinoma
of ovary, breast, and colon, whereas a heterogenous pattern (predominantly apical/luminal) was observed in welldifferentiated tumors.
Our current study explores the concept behind basolateral versus circumferential HER2 expression in gastric and
GE cancer using IHC technique. Well-differentiated tumor
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specimens showed a prominent if not exclusive basolateral
staining pattern. The loss of differentiation in cancer tissue
correlated with a circumferential staining of HER2, indicating a loss in cell polarity leading to migration of this antigen
along the cell membranes, also correlating with the loss of Ecadherin expression in poorly differentiated tumor cells.
In summary, our study shows that antigenic expression
in tumor cells is not static but rather a dynamic property
which can vary with tumor differentiation, cell adhesion, and
tight junction integrity. To the best of our knowledge this is
the first study which shows the frequency of circumferential
versus basolateral HER2 IHC staining in gastric adenocarcinoma and the plausible rational behind it. Even though the
conclusion in our study is based purely on our observations,
multiple previous studies do support this phenomenon of
heterogenous expression in various other types of antigens
and have found a link between expression pattern of membrane antigens with integrity of tight junctions.
This peculiar basolateral or lateral staining along with circumferential staining pattern forms the basis of HER2 scoring
for HER2 positivity and patient selection for Trastuzumab
therapy nationwide. An interesting question also arises:
whether variable antigen expression may also have implications on antibody localization and hence effectiveness of antiHER2 therapy as after all accessibility and binding of injected
antibody do depend on concentration as well as location of
antigen on tumor cell membranes. This needs experimentation on animal models.

5. Conclusion
These findings suggest that HER2 in gastric epithelium has
a polarized distribution which is maintained by the fence
function of tight junctions and adhesion molecules like Ecadherin on epithelial cells. With progression to high grade
cancer, the glandular structural differentiation in gastric
mucosa is lost, along with disruption of tight junctions. This
leads to loss of cell polarity and migration of antigens across
the membrane.
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